With regard to the role of Notch pathway in resistance of glioma stem cells, γ-secretase inhibitors cause glioma stem cells to be more vulnerable to therapy because of PI3K/Akt activation and overexpression of truncated apoptotic isoform of Mcl-1 [61]. The gene discussed is AKT1; the disease is glioma.